Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surmodics, Inc. - Common Stock (NQ:SRDX)

40.94 +13.60 (+49.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surmodics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session.
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Let's take a look at the stocks that are in motion in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump
 
Via Benzinga
Topics Stocks
What's Next: Surmodics's Earnings Preview
 
Via Benzinga
Earnings Scheduled For April 30, 2025
 
Via Benzinga
A Look at Surmodics's Upcoming Earnings Report
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge
A U.S. court denied the FTC's bid to block GTCR's $627 million acquisition of Surmodics, clearing the way for the merger to proceed. 
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
US Stocks Mixed; Sea Shares Gain After Q3 Results
 
Via Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session.
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article. 
Via Chartmill
Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR
From Surmodics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations
From Surmodics, Inc.
Via Business Wire
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3
From Surmodics, Inc.
Via Business Wire
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
From Surmodics, Inc.
Via Business Wire
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28
From Surmodics, Inc.
Via Business Wire
Surmodics Inc (NASDAQ:SRDX) Beats Q3 Earnings Estimates Despite Revenue Challenges, Raises Full-Year Guidance
Surmodics Inc (SRDX) beats Q3 earnings estimates with $0.06 EPS, raises FY2025 guidance. Revenue dips 3% but Pounce Thrombectomy grows 35%. Shares rise on improved profitability. 
Via Chartmill
Surmodics (SRDX) Q3 EPS Turns Positive
Via The Motley Fool
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Earnings Scheduled For August 8, 2025
 
Via Benzinga
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
From Surmodics, Inc.
Via Business Wire
9 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
From Surmodics, Inc.
Via Business Wire
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
From Surmodics, Inc.
Via Business Wire
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private
This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it's 2017 again. 
Via Benzinga
Why Surmodics Stock Is Falling On Friday
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.